Insights

More Articles Back to Article

Chinese may approve Pfizer/BioNTech vaccine this summer

Chinese health regulators are reportedly considering approval of the Pfizer/BioNTech COVID-19 vaccine this summer, which would be the first Western vaccine approved by the country. About 100 million doses are expected to be delivered to China by the end of the year through a deal with BioNTech and Shanghai Fosun Pharmaceutical Group Co. The Wall Street Journal (4/16)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!